Literature DB >> 11686402

Lipid-rich clear-cell hepatocellular carcinoma arising in non-alcoholic steatohepatitis in a patient with diabetes mellitus.

H Orikasa1, R Ohyama, N Tsuka, B P Eyden, K Yamazaki.   

Abstract

A case of lipid-rich clear-cell hepatocellular carcinoma arising in non-alcoholic steatohepatitis is described in a patient with diabetes mellitus. The patient was a 67 year-old Japanese female with a history of tuberculosis, appendicitis, ischaemic heart disease, and non-insulin-dependent diabetes mellitus. The patient denied alcohol consumption. A liver mass was diagnosed as hepatocellular carcinoma of clear-cell type with early cirrhosis of the peri-tumoral liver tissue. Tumour cells had clear cytoplasm containing lipid droplets, and Mallory bodies. Surrounding non-tumoral liver tissue also showed lipid, and fibrosis in peri-portal areas with moderate bridging fibrosis. The features were consistent with clear-cell hepatocellular carcinoma arising in the fibrosis of non-alcoholic steatohepatitis. By electron microscopy, tumour cells had lipid droplets, glycogen, swollen mitochondria, rough endoplasmic reticulum, Mallory bodies, small bile canaliculi, desmosomes and gap junctions. Surrounding non-tumoral hepatocytes had a largely normal ultrastructure with prominent glycogen and lipid droplets. Clear-cell hepatocellular carcinoma within non-alcoholic steatohepatitis associated with diabetes mellitus is an extremely rare condition, and this report provides a detailed histopathological description with both immunohistochemical and ultrastructural data.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11686402

Source DB:  PubMed          Journal:  J Submicrosc Cytol Pathol        ISSN: 1122-9497


  7 in total

Review 1.  Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review.

Authors:  Yoshitaka Takuma; Kazuhiro Nouso
Journal:  World J Gastroenterol       Date:  2010-03-28       Impact factor: 5.742

2.  Hepatocellular carcinoma and nonalcoholic steatohepatitis developing during long-term administration of valproic acid.

Authors:  Katsuaki Sato; Yoshimichi Ueda; Keiichi Ueno; Kazuya Okamoto; Hideaki Iizuka; Shogo Katsuda
Journal:  Virchows Arch       Date:  2005-08-17       Impact factor: 4.064

Review 3.  Recent advances in the development of farnesoid X receptor agonists.

Authors:  Ahmad H Ali; Elizabeth J Carey; Keith D Lindor
Journal:  Ann Transl Med       Date:  2015-01

4.  Epidemiology of primary and secondary liver cancers.

Authors:  Ashwin Ananthakrishnan; Veena Gogineni; Kia Saeian
Journal:  Semin Intervent Radiol       Date:  2006-03       Impact factor: 1.513

5.  Multicentric occurrence of hepatocellular carcinoma with nonalcoholic steatohepatitis.

Authors:  Hirokazu Kawai; Minoru Nomoto; Takeshi Suda; Kenya Kamimura; Atsunori Tsuchiya; Yasushi Tamura; Masahiko Yano; Masaaki Takamura; Masato Igarashi; Toshifumi Wakai; Satoshi Yamagiwa; Yasunobu Matsuda; Shogo Ohkoshi; Isao Kurosaki; Yoshio Shirai; Masahiko Okada; Yutaka Aoyagi
Journal:  World J Hepatol       Date:  2011-01-27

Review 6.  Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review.

Authors:  Donna L White; Fasiha Kanwal; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2012-10-04       Impact factor: 11.382

7.  Hepatocellular carcinoma arising from nonalcoholic steatohepatitis: report of two cases.

Authors:  Seikan Hai; Shoji Kubo; Taichi Shuto; Hiromu Tanaka; Shigekazu Takemura; Takatsugu Yamamoto; Akishige Kanazawa; Masao Ogawa; Kazuhiro Hirohashi; Kenichi Wakasa
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.